Autopsy report · NCT04852029

Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes

“recruitment issues”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 4 months before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Reproductive Medicine Associates of New Jersey

Sponsor type

University, hospital or other

Conditions

Infertility, Female

Interventions

Low dose hCG

Participants

12

Sites

1

Countries

United States

Trials that died the same way

• Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
  “Issues with recruitment.” (97% match in meaning)
• Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus
  “Recruitment problems” (95% match in meaning)
• Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
  “Problems of recruitment” (94% match in meaning)
• Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
  “problems with recruitment” (93% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.